Treatment of Hunter syndrome patients with intravenous Elaprase provides exogenous enzyme for uptake into cellular lysosomes.
Hunteri sündroomiga patsientide ravimisel intravenoosse Elaprase' ga antakse rakkude lüsosoomidele eksogeenset ensüümi.